8.15BMarket Cap
16.63P/E TTM
TG Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of TG Therapeutics Inc is 8.97, ranking 58 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 16.63, which is 1506.93% below the recent high of 267.17 and 2175.07% above the recent low of -345.00.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.